GDC-0084
SJPI3K
Phase 1 small_molecule completed
Quick answer
GDC-0084 for Brain and Central Nervous System Tumors is a Phase 1 program (small_molecule) at KAZIA THERAPEUTICS LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- KAZIA THERAPEUTICS LTD
- Indication
- Brain and Central Nervous System Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed